AnalystsTony ButlerTony Butler's Stock Forecasts
AnalystsTony Butler
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4546 out of 4587 analysts
Average Return
-13.8%
Win Rate
35%40 out of 113
Risk vs Reward
Poor
Good
Tony Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +149.13% | $19.46 | $48.48 | 2023-02-28 - 2024-02-29 | Strong Buy |
Compugen LtdCGEN | +126.88% | $0.93 | $2.11 | 2023-05-23 - 2024-05-17 | Strong Buy |
Translate Bio IncTBIO1 | +113.12% | $17.76 | $37.85 | 2021-03-17 - 2021-08-04 | Strong Buy |
G1 Therapeutics IncGTHX | +111.68% | $2.14 | $4.53 | 2023-08-01 - 2024-05-17 | Strong Buy |
Compugen LtdCGEN | +110.23% | $0.88 | $1.85 | 2023-01-04 - 2024-01-04 | Strong Buy |
Tony Butler Analyst Color
Get additional color on Tony Butler's coverage of popular stocks
Tony Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Century Therapeutics IncIPSC | 5 | Strong Buy | $16.00 | +431.56% | Reiterates | 9 months ago |
Adaptimmune Therapeutics PLCADAP | 8 | Strong Buy | $10.00 | +800.90% | Reiterates | 9 months ago |
Fate Therapeutics IncFATE | 4 | Strong Buy | $10.00 | +156.41% | Reiterates | 9 months ago |
Crispr Therapeutics AgCRSP | 7 | Strong Buy | $75.00 | +33.40% | Reiterates | 9 months ago |
Merus NvMRUS | 7 | Strong Buy | $35.00 | -20.29% | Reiterates | 9 months ago |
Gt Biopharma IncGTBP | 5 | Hold | $60.00 | +1,823.08% | Reiterates | 9 months ago |
Compugen LtdCGEN | 6 | Strong Buy | $13.00 | +516.11% | Reiterates | 9 months ago |
Bicycle Therapeutics PLCBCYC | 5 | Strong Buy | $50.00 | +134.08% | Reiterates | 10 months ago |
Allogene Therapeutics IncALLO | 7 | Strong Buy | $15.00 | +441.52% | Reiterates | 10 months ago |
G1 Therapeutics IncGTHX | 4 | Strong Buy | $19.00 | +319.43% | Reiterates | 10 months ago |
Bioatla IncBCAB | 6 | Strong Buy | $25.00 | +783.39% | Reiterates | 10 months ago |
Biomea Fusion IncBMEA | 3 | Strong Buy | $43.00 | +251.31% | Reiterates | 10 months ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $15.00 | +261.45% | Initiates Coverage On | 10 months ago |
Viracta Therapeutics IncVIRX | 1 | Strong Buy | $10.00 | +1,139.16% | Initiates Coverage On | 10 months ago |
Cel Sci CorpCVM | 3 | Strong Buy | $10.00 | +687.40% | Reiterates | 10 months ago |
Calcimedica IncCALC | 2 | Strong Buy | $17.00 | +211.93% | Reiterates | 10 months ago |
Agenus IncAGEN | 4 | Strong Buy | $166.00 | +1,428.55% | Reiterates | a year ago |
Replimune Group IncREPL | 4 | Strong Buy | $60.00 | +831.68% | Reiterates | a year ago |
In8bio IncINAB | 4 | Strong Buy | $8.00 | +676.70% | Reiterates | a year ago |
Aravive IncARAV | 5 | Strong Buy | $10.00 | +24,900.00% | Reiterates | a year ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $6.00 | +679.22% | Assumes | a year ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $9.00 | +718.18% | Assumes | a year ago |
Rain Oncology IncRAIN | 6 | Hold | $2.00 | +65.29% | Maintains | a year ago |
Apexigen IncAPGN | 4 | Hold | $0.64 | +66.23% | Reiterates | a year ago |
Ocean Biomedical IncOCEA | 1 | Strong Buy | $17.00 | +865.91% | Assumes | a year ago |
Atreca IncBCEL | 2 | Strong Buy | $10.00 | N/A | Reiterates | a year ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $2.00 | N/A | Reiterates | a year ago |
Atara Biotherapeutics IncATRA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Ayala Pharmaceuticals IncAYLA | 2 | Strong Sell | $0.55 | N/A | Downgrades | 2 years ago |
Humanigen IncHGENQ | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Translate Bio IncTBIO1 | 4 | Hold | $684.00 | N/A | Maintains | 3 years ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $110.00 | N/A | Maintains | 3 years ago |
Panbela Therapeutics IncPBLA | 1 | Strong Buy | $240,000.00 | N/A | Initiates Coverage On | 3 years ago |
Nextcure IncNXTC | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 4 years ago |
Arqule IncARQL | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.